Eli Lilly And CompanyUsage: OLUMIANT® (baricitinib) is indicated for treating moderately to severely active rheumatoid arthritis in adults who have not responded to TNF blockers, COVID-19 in hospitalized adults requiring oxygen or ventilation, and severe alopecia areata. It should not be combined with other JAK inhibitors or potent immunosuppressants.